LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. – Trademark Portfolio
Entity Type: 99
LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include ERZOFRI, RYKINDO, and INNOMIND. The owner is based in SHIJIAZHUANG CITY.
5TH FLOOR, RUNJIANG HEADQUARTERS INTERNATIONAL BUILDING
NO. 455 YUHUA EAST ROAD, SHIJIAZHUANG HIGH-TECH ZONE
SHIJIAZHUANG CITY 050000 , CN
Showing of trademarks Trademarks
Trademark Classifications
LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. have?
LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. file in?
LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD.'s most well-known trademarks?
LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD.'s registered trademark portfolio includes well-known marks such as ERZOFRI, RYKINDO, and INNOMIND. These are among 4 currently registered trademarks in the portfolio.
What is LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD.'s trademark registration success rate?
LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.